These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3187286)
1. [Open question to those responsible for the measles-mumps-rubella vaccination program]. Gaillet RP Rev Med Suisse Romande; 1988 Aug; 108(8):711-6. PubMed ID: 3187286 [No Abstract] [Full Text] [Related]
2. [Response to: "Open question to those responsible for the MMR vaccination program" by Dr. R. Ph. Gaillet]. Méan F Rev Med Suisse Romande; 1988 Oct; 108(10):907-10. PubMed ID: 3206040 [No Abstract] [Full Text] [Related]
4. [The Communauté française' eradication plan for measles, mumps and rubella]. Berghmans L; Swennen B; Dachy A; Reginster R; Thieffry P; Drumaux P Arch Belg; 1989; 47(1-4):8-10. PubMed ID: 2610579 [TBL] [Abstract][Full Text] [Related]
5. [Combined vaccination against measles, rubella and mumps]. Suter S Rev Med Suisse Romande; 1985 Nov; 105(11):1051-4. PubMed ID: 4089387 [No Abstract] [Full Text] [Related]
6. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518 [TBL] [Abstract][Full Text] [Related]
8. [Vaccination against measles, mumps and rubella]. Lakartidningen; 1984 Apr; 81(16):1632-6. PubMed ID: 6717183 [No Abstract] [Full Text] [Related]
9. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults. Danon YL; Adir Y; Abend I; Zaaide Y; Green MS Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506 [No Abstract] [Full Text] [Related]
10. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Boulianne N; De Serres G; Ratnam S; Ward BJ; Joly JR; Duval B Vaccine; 1995 Nov; 13(16):1611-6. PubMed ID: 8578850 [TBL] [Abstract][Full Text] [Related]
12. Rational use of measles, mumps and rubella (MMR) vaccine. Carter H; Campbell H Drugs; 1993 May; 45(5):677-83. PubMed ID: 7686463 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella. Nasibov MN; Yakovleva NV; Smorodintsev AA Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205 [No Abstract] [Full Text] [Related]
15. Measles, mumps and rubella. The new MMR. Golding AM Public Health; 1988 Nov; 102(6):517-8. PubMed ID: 3231693 [No Abstract] [Full Text] [Related]
17. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases. Böttiger M; Christenson B; Strandell A; Romanus V Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776 [TBL] [Abstract][Full Text] [Related]
18. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
19. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. Beck M; Welsz-Malecek R; Mesko-Prejac M; Radman V; Juzbasic M; Rajninger-Miholic M; Prislin-Musklic M; Dobrovsak-Sourek V; Smerdel S; Stainer DW J Biol Stand; 1989 Jan; 17(1):85-90. PubMed ID: 2646300 [TBL] [Abstract][Full Text] [Related]
20. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]